Literature DB >> 19542908

The relationship of insulin resistance with SNP 276G>T at adiponectin gene and plasma long-chain polyunsaturated fatty acids in obese children.

Elvira Verduci1, Silvia Scaglioni, Carlo Agostoni, Giovanni Radaelli, Marialuisa Biondi, Ana S Manso, Enrica Riva, Marcello Giovannini.   

Abstract

This study examined the association of insulin resistance with single-nucleotide polymorphism (SNP) 276G>T at adiponectin gene and the plasma long-chain polyunsaturated fatty acids (LCPUFAs) profile in obese children. One hundred thirty-one normolipidaemic obese children aged 8-13 y (53 girls and 68 boys) entered the study. The prevalence of T allele carriers at SNP276 was 48.8%. Mean [SD] values of fasting insulin and homeostasis model assessment-insulin resistance (HOMA-IR) index in noncarriers versus carriers of T allele were 12.4 [6.4] versus 20.6 [6.3] muU/mL (p = 0.039) and 2.6 [1.4] versus 4.5 [1.7] (p = 0.032). Mean [SD] values of plasma C18:3n - 3, C20:5n - 3/C20:4n - 6, and n - 6/n - 3 LCPUFA in phospholipids in noncarriers versus carriers of T allele were 0.10 [0.04] versus 0.08 [0.03] % (p = 0.013), 0.04 [0.01] versus 0.03 [0.01] % (p = 0.045), and 4.4 [0.7] versus 4.9 [0.9] % (p = 0.005), respectively. Insulin resistance was independently associated with SNP 276G>T (p = 0.002) and n - 6/n - 3 LCPUFA (p = 0.042) in plasma phospholipids, and interaction was found between SNP 276G>T and n - 6/n - 3 LCPUFA (p = 0.046). These findings suggest that obese children carriers of the SNP 276G>T may be at increased risk of metabolic complications compared with noncarriers, possibly due in part to a different plasma phospholipids profile.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542908     DOI: 10.1203/PDR.0b013e3181b1bc4a

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

Review 1.  Interactions between dietary n-3 fatty acids and genetic variants and risk of disease.

Authors:  Dolores Corella; José M Ordovás
Journal:  Br J Nutr       Date:  2012-06       Impact factor: 3.718

2.  Meta-analysis of the association of ADIPOQ G276T polymorphism with insulin resistance and blood glucose.

Authors:  Shengrong Ouyang; Dingding Cao; Zhuo Liu; Feifei Ma; Jianxin Wu
Journal:  Endocrine       Date:  2014-06-11       Impact factor: 3.633

3.  Associations between two single nucleotide polymorphisms of the adiponectin gene, its circulating concentrations and cardiometabolic risk factors in prepubertal children with and without abdominal obesity.

Authors:  S V Galcheva; D Martorana; V M Iotova; Y Yotov; T M Neri; M E Street
Journal:  J Endocrinol Invest       Date:  2013-05-22       Impact factor: 4.256

4.  Variations in Adipokine Genes AdipoQ, Lep, and LepR are Associated with Risk for Obesity-Related Metabolic Disease: The Modulatory Role of Gene-Nutrient Interactions.

Authors:  Jennifer Emily Enns; Carla G Taylor; Peter Zahradka
Journal:  J Obes       Date:  2011-04-19

Review 5.  Role of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and Humans.

Authors:  Chao-Wei Huang; Yi-Shan Chien; Yu-Jen Chen; Kolapo M Ajuwon; Harry M Mersmann; Shih-Torng Ding
Journal:  Int J Mol Sci       Date:  2016-10-09       Impact factor: 5.923

6.  Lower Levels of Serum Adiponectin and the T Allele of rs1501299 of the ADIPOQ Gene Are Protective against Polycystic Ovarian Syndrome in Jordan.

Authors:  Mahmoud A Alfaqih; Yousef S Khader; Ahmed N Al-Dwairi; Abdallah Alzoubi; Othman Al-Shboul; Amanie Hatim
Journal:  Korean J Fam Med       Date:  2018-03-22

Review 7.  Docosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link?

Authors:  Carlotta Lassandro; Giuseppe Banderali; Giovanni Radaelli; Elisa Borghi; Francesca Moretti; Elvira Verduci
Journal:  Int J Mol Sci       Date:  2015-08-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.